Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
A randomized, double-blind, parallel group, placebo and active (prednisone) controlled, 6-week study of the effect of GW685698X aqueous nasal spray 100mcg QD on the hypothalamic pituitary adrenocortical (HPA) axis in adolescents and adults 12 to 65 years of age with perennial allergic rhinitis (PAR).
Age
12–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis and history of perennial allergic rhinitis.
Must be willing to stay overnight in the clinic at the beginning and end of the study for the collection of urine and blood samples over 24 hours.
Must comply with all study procedures and be literate.
You may not be if
Use of tobacco products.
Work a rotating shift.
Significant concurrent medical conditions.
Certain medications such as corticosteroids and allergy medications.
Clareo Health | A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults
